Jeffrey Switchenko

27PUBLICATIONS

155CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsCancer geneticsMedical virology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (27)

Sort by Publication Date:

|Jul 08, 2026

Real-World Implementation of Tarlatamab-Dlle Therapy for Patients With Extensive-Stage Small Cell Lung Cancer and Other High-Grade Neuroendocrine Neoplasms.

|Feb 17, 2026

Receipt of guideline-concordant local and chemotherapy-based systemic therapy for patients with triple-negative breast cancer: 10-year survival outcomes in a multi-state population-based analysis.

Joseph Lipscomb, Gretchen G Kimmick, J Frank Wilson

|May 12, 2025

Early-Phase Trial of IAP Antagonist Tolinapant and Definitive Radiation in Cisplatin-Ineligible Patients with Advanced Head and Neck Cancer.

Nicole C Schmitt, William A Stokes, James E Bates

|Jul 07, 2023

Shifting Sociodemographic Characteristics of a Phase I Clinical Trial Population at an NCI-Designated Comprehensive Cancer Center in the Southeast.

Chloe S Lalonde, Jeffrey M Switchenko, Madhusmita Behera

|Feb 22, 2023

A multicenter analysis of the outcomes with venetoclax in patients with relapsed mantle cell lymphoma.

Yazeed Sawalha, Subir Goyal, Jeffrey M Switchenko

|Dec 16, 2022

Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.

Pamela B Allen, Ashley A McCook-Veal, Jeffrey M Switchenko

Pageof 5

Frequent Collaborators

Jonathon Cohen

Brad S Kahl

Rajesh Valanparambil

Mehul S Suthar

Reem Karmali

Natalie Sophia Grover

Rajesh Valanparambil

Jean L Koff

Nabil F Saba

Ajay K Nooka

Frequent Collaborators

Jonathon Cohen

Brad S Kahl

Rajesh Valanparambil

Mehul S Suthar